SFC Fluidics, Inc. Receives SBIR Phase II Funding for Development of an Implantable Drug Delivery Device

By | Funding

FAYETTEVILLE, AR – SFC Fluidics® is very pleased to announce it has received $1.4 million in Phase II Small Business Innovation Research funding from the National Institutes of Health for the development of an implantable, wirelessly controlled, rapid dosing drug delivery system for small animal research. The min-ePump™ implantable drug delivery…

Read More